Login / Signup

The impact of surging transplantation of alcohol-associated liver disease on transplantation for HCC and other indications.

Divya Ayyala-SomayajulaJennifer L DodgeKali ZhouNorah A TerraultLiyun Yuan
Published in: Hepatology communications (2024)
The high volume of LT for ALD does not impact waitlist mortality for HCC and others but affects LT probability for other in the MMAT-3 era warranting continued monitoring.
Keyphrases
  • cell therapy
  • cardiovascular events
  • risk factors
  • type diabetes
  • stem cells
  • coronary artery disease